Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
Clinical trial NCT03409107 · COMPLETED
Trial details
- NCT number
- NCT03409107
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-05
- Primary completion
- 2020-10-07
- Enrollment
- 614
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.